These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 20951783

  • 21. Tamoxifen citrate loaded amphiphilic beta-cyclodextrin nanoparticles: in vitro characterization and cytotoxicity.
    Memisoglu-Bilensoy E, Vural I, Bochot A, Renoir JM, Duchene D, Hincal AA.
    J Control Release; 2005 Jun 02; 104(3):489-96. PubMed ID: 15911048
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Conjugates of poly(DL-lactide-co-glycolide) on amino cyclodextrins and their nanoparticles as protein delivery system.
    Gao H, Wang YN, Fan YG, Ma JB.
    J Biomed Mater Res A; 2007 Jan 02; 80(1):111-22. PubMed ID: 16960831
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Treatment of malignant gliomas with mitoxantrone-loaded poly (lactide-co-glycolide) microspheres.
    Yemisci M, Bozdag S, Cetin M, Söylemezoglu F, Capan Y, Dalkara T, Vural I.
    Neurosurgery; 2006 Dec 02; 59(6):1296-302; discussion 1302-3. PubMed ID: 17277693
    [Abstract] [Full Text] [Related]

  • 26. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F, d'Emmanuele di Villa Bianca R, Giovino C, Miro A, Sorrentino R, Quaglia F, La Rotonda MI.
    J Control Release; 2009 Apr 02; 135(1):25-34. PubMed ID: 19154761
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.
    Patil Y, Sadhukha T, Ma L, Panyam J.
    J Control Release; 2009 May 21; 136(1):21-9. PubMed ID: 19331851
    [Abstract] [Full Text] [Related]

  • 29. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK, Mishra P, Mishra AK, Mishra P, Jain S, Agrawal GP.
    Nanomedicine; 2007 Dec 21; 3(4):246-57. PubMed ID: 18068091
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion.
    Huang ZR, Hua SC, Yang YL, Fang JY.
    Acta Pharmacol Sin; 2008 Sep 21; 29(9):1094-102. PubMed ID: 18718178
    [Abstract] [Full Text] [Related]

  • 32. Polysaccharide surface modified Fe3O4 nanoparticles for camptothecin loading and release.
    Zhu A, Yuan L, Jin W, Dai S, Wang Q, Xue Z, Qin A.
    Acta Biomater; 2009 Jun 21; 5(5):1489-98. PubMed ID: 19286431
    [Abstract] [Full Text] [Related]

  • 33. Designing bioresorbable polyester matrices for controlled doxorubicin release in glioma therapy.
    Kasperczyk J, Stoklosa K, Dobrzynski P, Stepien K, Kaczmarczyk B, Dzierzega-Lecznar A.
    Int J Pharm; 2009 Dec 01; 382(1-2):124-9. PubMed ID: 19715746
    [Abstract] [Full Text] [Related]

  • 34. Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: preparation, characterization and application to the transport of acyclovir.
    Ghera BB, Perret F, Chevalier Y, Parrot-Lopez H.
    Int J Pharm; 2009 Jun 22; 375(1-2):155-62. PubMed ID: 19481701
    [Abstract] [Full Text] [Related]

  • 35. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan.
    Sepehri N, Rouhani H, Tavassolian F, Montazeri H, Khoshayand MR, Ghahremani MH, Ostad SN, Atyabi F, Dinarvand R.
    Int J Pharm; 2014 Aug 25; 471(1-2):485-97. PubMed ID: 24879937
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S, Mukherjee S, Ray S, Thakur RS, Ghosh LK, Gupta BK.
    Pak J Pharm Sci; 2007 Apr 25; 20(2):157-62. PubMed ID: 17416573
    [Abstract] [Full Text] [Related]

  • 38. Development of a new delivery system consisting in 'drug-in cyclodextrin-in PLGA nanoparticles'.
    Mura P, Maestrelli F, Cecchi M, Bragagni M, Almeida A.
    J Microencapsul; 2010 Apr 25; 27(6):479-86. PubMed ID: 20113170
    [Abstract] [Full Text] [Related]

  • 39. Cyclodextrin nanoparticle bound oral camptothecin for colorectal cancer: Formulation development and optimization.
    Ünal S, Aktaş Y, Benito JM, Bilensoy E.
    Int J Pharm; 2020 Jun 30; 584():119468. PubMed ID: 32470483
    [Abstract] [Full Text] [Related]

  • 40. Cytotoxic evaluation of injectable cyclodextrin nanoparticles.
    Memisoglu-Bilensoy E, Doğan AL, Hincal AA.
    J Pharm Pharmacol; 2006 May 30; 58(5):585-9. PubMed ID: 16640826
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.